89 related articles for article (PubMed ID: 10072913)
1. Molecular modeling of mu opioid receptor and receptor-ligand interaction.
Rong SB; Zhu YC; Jiang HL; Zhao SR; Wang QM; Chi ZQ; Chen KX; Ji RY
Zhongguo Yao Li Xue Bao; 1997 Jul; 18(4):317-22. PubMed ID: 10072913
[TBL] [Abstract][Full Text] [Related]
2. Molecular modeling of mu opioid receptor and its interaction with ohmefentanyl.
Tang Y; Chen KX; Jiang HL; Wang ZX; Ji RY; Chi ZQ
Zhongguo Yao Li Xue Bao; 1996 Mar; 17(2):156-60. PubMed ID: 9772668
[TBL] [Abstract][Full Text] [Related]
3. Molecular modeling of interaction between delta opioid receptor and 3-methylfentanylisothiocyanate.
Rong SB; Jiang HL; Chi ZQ; Chen KX; Zhu YC; Ji RY
Zhongguo Yao Li Xue Bao; 1997 May; 18(3):219-24. PubMed ID: 10072937
[TBL] [Abstract][Full Text] [Related]
4. Steric interactions and the activity of fentanyl analogs at the mu-opioid receptor.
Dosen-Micovic L; Ivanovic M; Micovic V
Bioorg Med Chem; 2006 May; 14(9):2887-95. PubMed ID: 16376082
[TBL] [Abstract][Full Text] [Related]
5. Molecular modeling on solvent effect and interaction mechanism of fentanyl analogs to mu-opioid receptor.
Huang XQ; Jiang HL; Luo XM; Rong SB; Gu JD; Tan XJ; Zhu YC; Chen KX; Ji RY; Cao Y
Acta Pharmacol Sin; 2000 Jan; 21(1):46-54. PubMed ID: 11263247
[TBL] [Abstract][Full Text] [Related]
6. Opioid peptide receptor studies, 11: involvement of Tyr148, Trp318 and His319 of the rat mu-opioid receptor in binding of mu-selective ligands.
Xu H; Lu YF; Partilla JS; Zheng QX; Wang JB; Brine GA; Carroll FI; Rice KC; Chen KX; Chi ZQ; Rothman RB
Synapse; 1999 Apr; 32(1):23-8. PubMed ID: 10188634
[TBL] [Abstract][Full Text] [Related]
7. Homology models of mu-opioid receptor with organic and inorganic cations at conserved aspartates in the second and third transmembrane domains.
Zhorov BS; Ananthanarayanan VS
Arch Biochem Biophys; 2000 Mar; 375(1):31-49. PubMed ID: 10683246
[TBL] [Abstract][Full Text] [Related]
8. Molecular modeling on kappa opioid receptor and its interaction with nonpeptide kappa opioid agonists.
Liu DX; Jiang HL; Shen JS; Zhu WL; Zhao L; Chen KX; Ji RY
Zhongguo Yao Li Xue Bao; 1999 Feb; 20(2):131-6. PubMed ID: 10437159
[TBL] [Abstract][Full Text] [Related]
9. Interaction models of 3-methylfentanyl derivatives with mu opioid receptors.
Rong SB; Zhu YC; Jiang HL; Wang QM; Zhao SR; Chen KX; Ji RY
Zhongguo Yao Li Xue Bao; 1997 Mar; 18(2):128-32. PubMed ID: 10072963
[TBL] [Abstract][Full Text] [Related]
10. Complex of an active mu-opioid receptor with a cyclic peptide agonist modeled from experimental constraints.
Fowler CB; Pogozheva ID; Lomize AL; LeVine H; Mosberg HI
Biochemistry; 2004 Dec; 43(50):15796-810. PubMed ID: 15595835
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and pharmacological studies of new hybrid derivatives of fentanyl active at the mu-opioid receptor and I2-imidazoline binding sites.
Dardonville C; Fernandez-Fernandez C; Gibbons SL; Ryan GJ; Jagerovic N; Gabilondo AM; Meana JJ; Callado LF
Bioorg Med Chem; 2006 Oct; 14(19):6570-80. PubMed ID: 16797997
[TBL] [Abstract][Full Text] [Related]
12. Molecular modeling of interactions between tetrahydroprotoberberines and dopamine receptors.
Tang Y; Chen KX; Jiang HL; Jin GZ; Ji RY
Zhongguo Yao Li Xue Bao; 1996 Jan; 17(1):8-12. PubMed ID: 8737443
[TBL] [Abstract][Full Text] [Related]
13. Molecular docking reveals a novel binding site model for fentanyl at the mu-opioid receptor.
Subramanian G; Paterlini MG; Portoghese PS; Ferguson DM
J Med Chem; 2000 Feb; 43(3):381-91. PubMed ID: 10669565
[TBL] [Abstract][Full Text] [Related]
14. Building 3D-structural model of kappa opioid receptor and studying its interaction mechanism with dynorphin A(1-8).
Wan XH; Huang XQ; Zhou DH; Jiang HL; Chen KX; Chi ZQ
Acta Pharmacol Sin; 2000 Aug; 21(8):701-8. PubMed ID: 11501178
[TBL] [Abstract][Full Text] [Related]
15. Selected cysteine residues in transmembrane domains of mu-opioid receptor are critical for effects of sulfhydryl reagents.
Deng HB; Guang W; Wang JB
J Pharmacol Exp Ther; 2000 Apr; 293(1):113-20. PubMed ID: 10734160
[TBL] [Abstract][Full Text] [Related]
16. Molecular determinants of mu receptor recognition for the fentanyl class of compounds.
Cometta-Morini C; Maguire PA; Loew GH
Mol Pharmacol; 1992 Jan; 41(1):185-96. PubMed ID: 1310142
[TBL] [Abstract][Full Text] [Related]
17. Homology modeling and molecular dynamics simulations of the mu opioid receptor in a membrane-aqueous system.
Zhang Y; Sham YY; Rajamani R; Gao J; Portoghese PS
Chembiochem; 2005 May; 6(5):853-9. PubMed ID: 15776407
[TBL] [Abstract][Full Text] [Related]
18. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
[TBL] [Abstract][Full Text] [Related]
19. Refinement of a homology model of the mu-opioid receptor using distance constraints from intrinsic and engineered zinc-binding sites.
Fowler CB; Pogozheva ID; LeVine H; Mosberg HI
Biochemistry; 2004 Jul; 43(27):8700-10. PubMed ID: 15236578
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of 4-(N,N-diarylamino)piperidines with high selectivity to the delta-opioid receptor: a combined 3D-QSAR and ligand docking study.
Podlogar BL; Poda GI; Demeter DA; Zhang SP; Carson JR; Neilson LA; Reitz AB; Ferguson DM
Drug Des Discov; 2000; 17(1):34-50. PubMed ID: 10928448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
